Venlafaxine Hydrochloride
Product Images NDC 68151-3660

6 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68151-3660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl681513660)

Label Image (Lbl681513660)
Label of Venlafaxine Hydrochloride 75 mg ER capsules showing manufacturer Greenstone, lot number H76335, expiration date 08/14, with barcode and product code 3660. The label indicates the product is prescription only.*
FDA Label Image

Figure 1 (Venlafaxine 01)

Figure 1 (Venlafaxine 01)
A pharmacokinetic chart showing the effect of various interacting drugs on venlafaxine and its analytes' Cmax and AUC values. It displays fold changes and 90% confidence intervals relative to a reference value, with recommendations such as avoiding concomitant use or using caution for specific drug interactions.*
FDA Label Image

Figure 2 (Venlafaxine 02)

Figure 2 (Venlafaxine 02)
A scatter plot chart showing pharmacokinetic (PK) fold changes of various interacting drugs relative to a reference value, with 90% confidence intervals. The plot compares Cmax and AUC values for different analytes such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The chart includes recommendations for each drug interaction, such as dose adjustment advice or clinical significance notes.*
FDA Label Image

Figure 3 (Venlafaxine 03)

Figure 3 (Venlafaxine 03)
A forest plot chart illustrating the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its ODV metabolite across special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphisms, age, and gender. The chart also provides dosing recommendations based on these pharmacokinetic changes relative to reference values.*
FDA Label Image

Chemical Structure (Venlafaxine 04)

Chemical Structure (Venlafaxine 04)
Chemical structure of venlafaxine hydrochloride shown with labeled molecular groups, including hydroxyl, methoxy, and dimethylamino substituents, alongside a cyclohexane ring and aromatic ring.*
FDA Label Image

Logo (Venlafaxine 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.